All In MedTech

FDA Clearance Tracker · P010052-S007

IMMULITE/IMMULITE 1000 & IMMULITE 2000 ANTI-HBS

A PMA supplement is a change to a device that already has premarket approval, such as a new indication, a design change or a manufacturing change.

Last checked: Nov 20, 2026Latest source record: Jan 20, 2010 (this decision)Source: openFDAMethods & limitations

PMA supplement

The decision

FDA number
P010052-S007
Device name
IMMULITE/IMMULITE 1000 & IMMULITE 2000 ANTI-HBS
Applicant location
Llanberis
Received
Nov 2, 2009
Decided
Jan 20, 2010
Decision
Approved
Supplement type
Normal 180 Day Track No User Fee
Reason for supplement
Location Change - Manufacturer/Sterilizer/Packager/Supplier
Original approval
P010052

Device type

Device class
Class II
Regulation
21 CFR 866.3172

Every decision under product code LOM

FDA's approval statement

As written in FDA's record.

APPROVAL FOR A MANUFACTURING SITE LOCATED AT SIEMENS HEALTHCARE DIAGNOSTICS, NEWARK, DELAWARE FOR IMMULITE SUBSTRATE MANUFACTURING.

Source documents

Other decisions for Siemens Healthcare Diagnostics Products, Ltd.

Matched on the applicant name as FDA recorded it. A company that files under several names will have more.

Company page

5 more FDA decisions with a free account

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.